ALK probe rearrangement in a t(2;11;(2)under-bar)(p23;p15;(q31)double-under-bar) translocation found in a prenatal myofibroblastic fibrous lesion: Toward a molecular definition of an inflammatory myofibroblastic tumor family?
N. Sirvent et al., ALK probe rearrangement in a t(2;11;(2)under-bar)(p23;p15;(q31)double-under-bar) translocation found in a prenatal myofibroblastic fibrous lesion: Toward a molecular definition of an inflammatory myofibroblastic tumor family?, GENE CHROM, 31(1), 2001, pp. 85-90
A prenatal tumor located in the lumbar paravertebral area was discovered du
ring a routine ultrasound examination at 32 weeks of pregnancy and surgical
ly removed at 4 months of life. The histopathological diagnosis was first s
uggested to be an infantile desmoid fibromatosis. The tumor karyotype showe
d a three-way translocation involving both chromosomes 2 and a chromosome I
I, t(2;11;2)(p23;p 15;q31). Fluorescence in situ hybridization with a prob
e flanking the ALK gene at 2p23 demonstrated a rearrangement, as previously
described in inflammatory myofibroblastic tumors (IMTs). In light of the g
enetic analysis, the histopathological diagnosis was revised to IMT, althou
gh inflammatory cells were scarce. IMTs are pseudosarcomatous inflammatory
lesions that primarily occur in the soft tissue and viscera of children and
young adults. Our report describes for the first time the occurrence of IM
T during prenatal life. The ALK rearrangement may represent the molecular d
efinition of a subgroup of mesenchymal tumors, not always with complete mor
phological features of IMT, similar to the model of EWS rearrangement in th
e Ewing sarcoma family of tumors. (C) 2001 Wiley-Liss, Inc.